TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 89 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,219,000 | -42.5% | 1,048,642 | +17.9% | 0.50% | -45.2% |
| Q4 2017 | $5,601,000 | -9.0% | 889,100 | -1.2% | 0.92% | +0.5% |
| Q3 2017 | $6,156,000 | +415.6% | 900,000 | +462.3% | 0.91% | +1280.3% |
| Q3 2015 | $1,194,000 | -93.8% | 160,047 | -83.3% | 0.07% | -96.7% |
| Q3 2014 | $19,137,000 | -66.5% | 959,247 | -77.3% | 2.01% | -28.6% |
| Q2 2014 | $57,082,000 | +161.0% | 4,231,494 | +110.7% | 2.81% | +32.6% |
| Q1 2014 | $21,868,000 | -26.3% | 2,008,125 | -8.4% | 2.12% | -45.8% |
| Q4 2013 | $29,654,000 | +45.3% | 2,193,328 | +22.3% | 3.91% | +7.9% |
| Q3 2013 | $20,408,000 | +103.2% | 1,793,328 | +25.6% | 3.62% | +84.5% |
| Q2 2013 | $10,041,000 | – | 1,428,314 | – | 1.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |